Junyi Dai
Chief Executive Officer at Indaptus Therapeutics, Inc. (INDP) since March 2026
Junyi Dai has filed 2 insider reports with the SEC since May 2024, as chief Executive Officer at Indaptus Therapeutics, Inc. (INDP) and director at Mega Matrix Corp. (MPU). The latest filing, on April 2, 2026, is a Form 3: Junyi Dai became an insider at Indaptus Therapeutics, Inc. (INDP).
- Filings
- 2
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Junyi Dai is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officersince March 2026 | 11,250,000 | $3.45 | Apr 2, 2026 | ||||
| Directorsince May 2024 | $1.28 | May 14, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 23, 2026INDPJunyi Dai became an insiderForm 3New insider
- May 10, 2024MPUJunyi Dai became an insiderForm 3New insider
Compare Junyi Dai with
- Junyi Dai vs David E. Lazar1 shared
- Junyi Dai vs Yunhao Chen1 shared
- Junyi Dai vs Yucheng Hu1 shared
- Junyi Dai vs Qin Yao1 shared
- Junyi Dai vs Jerome D Jabbour1 shared
- Junyi Dai vs Matthew Charles McMurdo1 shared
Other insiders at the same companies
- Qinglai LuINDP
- Yun YaoINDP
- SINO LION VENTURES LtdINDP
- David E. LazarINDP
- Yunhao ChenMPU
- Jie MaMPU
- Yucheng HuMPU
- Yaman DemirMPU
- Qin YaoMPU
- Jerome D JabbourINDP
- Matthew Charles McMurdoINDP
- Jeffrey A MecklerINDP
- Avraham Ben-TzviINDP
- David NatanINDP
- Walt Addison LinscottINDP
- Michael James NewmanINDP
Questions about Junyi Dai
- What is Junyi Dai's role at Indaptus Therapeutics, Inc.?
- Junyi Dai reports to the SEC as chief Executive Officer at Indaptus Therapeutics, Inc. (INDP), according to the latest filing on April 2, 2026. Junyi Dai has also filed as director at Mega Matrix Corp. (MPU).
- How many shares does Junyi Dai own?
- After the latest filing that states it, Junyi Dai directly owned 11,250,000 shares of Indaptus Therapeutics, Inc. (INDP). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Junyi Dai bought or sold stock recently?
- No open-market purchases or sales by Junyi Dai are on file.
- How do I get alerts when Junyi Dai files?
- Follow Junyi Dai on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Junyi Dai (SEC CIK 0002022463). Totals count each trade once, skipping amendments whose original is on file, from May 14, 2024 on. View on SEC EDGAR